HALIFAX — New Brunswick Public Health reported 17 new cases of COVID-19 on Thursday. Public health also reported eight recoveries, putting the number of active cases at 121. "There are six people hospitalized due to the virus, with four in an intensive-care unit," public health said in a news release. Here is a breakdown of the new cases: Additional information is available on the COVID-19 dashboard. COVID-19 CASE DATA New Brunswick has had 2,885 cumulative cases of COVID-19 since the start of the pandemic. In total, 2,716 people have recovered, and 47 people have died in the province from COVID-19. Public health says a total of 419,428 COVID-19 tests have been processed since the start of the pandemic. The number of cases are broken down by New Brunswick’s seven health zones: VACCINATION STATUS UPDATE Public Health reported that 76.4 per cent of eligible New Brunswickers are fully vaccinated against COVID-19 and 85.3 per cent have received their first dose. "If you have not yet had your first or second dose, you are asked to go to a walk-in clinic or book an appointment through a participating pharmacy or at a Vitalité or Horizon health network clinic as soon as possible," public health said in the news release. "All eligible New Brunswickers can book their second-dose appointments for a date that is at least 28 days after their first dose." If you go to vaccination clinic, you are asked to bring your Medicare card, a signed consent form and, for those receiving their second dose, a copy of the record of immunization provided after receiving their first dose. A list of upcoming mobile and walk-in clinics is available online. MOBILE VACCINATION CLINIC A mobile vaccination clinic for those who have not yet received their first or second dose of a COVID-19 vaccine is taking place on Saturday at the New Brunswick Provincial Exhibition in Fredericton between 1 p.m. and 5 p.m. "This clinic will be administering the Pfizer-BioNTech vaccine which is suitable for people 12 and older and which can be used safely and effectively as either a first or second dose," public health said in a news release.
